InspireMD (NSPR) Long-Term Deferred Tax (2015 - 2016)
InspireMD (NSPR) reported Long-Term Deferred Tax of $29.6 million for Q4 2016, up 2.75% on a YoY basis from $28.8 million in Q1 2016, and up 2.75% quarter-over-quarter from $28.8 million in Q4 2015.
InspireMD (NSPR) Long-Term Deferred Tax (2015 - 2016) Analysis & Trends
InspireMD has reported Long-Term Deferred Tax for 2 years, with the latest figure at $29.6 million in Q4 2016.
- For the quarter ending Q4 2016, Long-Term Deferred Tax rose 2.75% year-over-year to $29.6 million; the trailing twelve-month figure through Dec 2016 stood at $29.6 million (up 2.75% YoY), and the FY2016 full-year result was $29.6 million, up 2.75% from the prior year.
- Long-Term Deferred Tax for Q4 2016 stood at $29.6 million, up from $28.8 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $29.6 million in Q4 2016, with the low at $28.8 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 29.58 Mn |
| Dec 31, 2015 | 28.79 Mn |